GH
Price
$41.79
Change
-$1.70 (-3.91%)
Updated
Apr 3, 02:59 PM (EDT)
Capitalization
2.46B
34 days until earnings call
GKOS
Price
$89.78
Change
-$10.26 (-10.26%)
Updated
Apr 3, 02:41 PM (EDT)
Capitalization
4.61B
27 days until earnings call
Ad is loading...

GH vs GKOS

Header iconGH vs GKOS Comparison
Open Charts GH vs GKOSBanner chart's image
Guardant Health
Price$41.79
Change-$1.70 (-3.91%)
Volume$700
Capitalization2.46B
Glaukos
Price$89.78
Change-$10.26 (-10.26%)
Volume$6.14K
Capitalization4.61B
GH vs GKOS Comparison Chart
Loading...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GH vs. GKOS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a Hold and GKOS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (GH: $43.49 vs. GKOS: $100.04)
Brand notoriety: GH: Notable vs. GKOS: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 54% vs. GKOS: 88%
Market capitalization -- GH: $2.46B vs. GKOS: $4.61B
GH [@Medical Specialties] is valued at $2.46B. GKOS’s [@Medical Specialties] market capitalization is $4.61B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileGKOS’s FA Score has 0 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • GKOS’s FA Score: 0 green, 5 red.
According to our system of comparison, GKOS is a better buy in the long-term than GH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GH’s TA Score shows that 5 TA indicator(s) are bullish while GKOS’s TA Score has 4 bullish TA indicator(s).

  • GH’s TA Score: 5 bullish, 5 bearish.
  • GKOS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GH and GKOS are a good buy in the short-term.

Price Growth

GH (@Medical Specialties) experienced а -5.13% price change this week, while GKOS (@Medical Specialties) price change was -3.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.03%. For the same industry, the average monthly price growth was +1.96%, and the average quarterly price growth was +1.63%.

Reported Earning Dates

GH is expected to report earnings on May 07, 2025.

GKOS is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-4.03% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GKOS($4.61B) has a higher market cap than GH($2.47B). GH YTD gains are higher at: 42.357 vs. GKOS (-33.280). GKOS has higher annual earnings (EBITDA): -82.12M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. GKOS (295M). GKOS has less debt than GH: GKOS (384M) vs GH (1.35B). GH has higher revenues than GKOS: GH (564M) vs GKOS (315M).
GHGKOSGH / GKOS
Capitalization2.47B4.61B54%
EBITDA-433.3M-82.12M528%
Gain YTD42.357-33.280-127%
P/E RatioN/AN/A-
Revenue564M315M179%
Total Cash1.17B295M396%
Total Debt1.35B384M353%
FUNDAMENTALS RATINGS
GH vs GKOS: Fundamental Ratings
GH
GKOS
OUTLOOK RATING
1..100
7412
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
93
Overvalued
PROFIT vs RISK RATING
1..100
10037
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
3665
P/E GROWTH RATING
1..100
10055
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GH's Valuation (66) in the Medical Or Nursing Services industry is in the same range as GKOS (93) in the Medical Specialties industry. This means that GH’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's Profit vs Risk Rating (37) in the Medical Specialties industry is somewhat better than the same rating for GH (100) in the Medical Or Nursing Services industry. This means that GKOS’s stock grew somewhat faster than GH’s over the last 12 months.

GKOS's SMR Rating (95) in the Medical Specialties industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that GKOS’s stock grew similarly to GH’s over the last 12 months.

GH's Price Growth Rating (36) in the Medical Or Nursing Services industry is in the same range as GKOS (65) in the Medical Specialties industry. This means that GH’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (55) in the Medical Specialties industry is somewhat better than the same rating for GH (100) in the Medical Or Nursing Services industry. This means that GKOS’s stock grew somewhat faster than GH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GHGKOS
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
67%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AWAY20.090.24
+1.23%
Amplify Travel Tech ETF
FDWM21.970.24
+1.11%
Fidelity Women's Leadership ETF
PCGG11.220.09
+0.79%
Polen Capital Global Growth ETF
PFXF16.660.03
+0.18%
VanEck Pref Secs ex Fincls ETF
MVF7.10N/A
N/A
BlackRock MuniVest Fund

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
+3.04%
ISRG - GKOS
45%
Loosely correlated
+2.15%
RDNT - GKOS
43%
Loosely correlated
+3.73%
NTRA - GKOS
42%
Loosely correlated
+1.81%
ICUI - GKOS
41%
Loosely correlated
+1.87%
AORT - GKOS
40%
Loosely correlated
+1.54%
More